Cartesian Therapeutics, Inc.

Research Cartesian Therapeutics, Inc. (1S70) on Bullrun: market cap EUR 243.87M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker1S70
• ExchangeF
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 243.87M
• Financial periodQ1 2026
• RevenueEUR 78.00K
• Net income-EUR 39.18M
• Free cash flow-EUR 22.16M

Valuation Snapshot

latest market cap is EUR 243.87M.

About Cartesian Therapeutics, Inc.

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases.

Frequently asked questions

What is Cartesian Therapeutics, Inc.'s market cap?

Cartesian Therapeutics, Inc.'s market capitalization is EUR 243.87M.

What does Cartesian Therapeutics, Inc. do?

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases.